FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL
Links shared publicly online about this topic.
- 457total visits
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BANZEL® (rufinamide) Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated wit
View full resource at medicalnewstoday.com
Tags: Seizure, Diet and Nutrition, Drug, Children's Health, FDA, Eisai
Most Recently Shared on March 7, 2011 at 10:48 pm By:
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL http://t.co/OEdVHPm via @mnt_epilepsy
Also Shared By:
Advertisement
MNT Pediatrics News
@mnt_pediatrics
FDA Approves BANZEL(R) (Rufinamide) Oral Suspension, 40 Mg/mL http://mnt.to/3RTV #pediatrics
1 year ago...